Genome-Wide Association Analysis in Primary Sclerosing Cholangitis

Gastroenterology

Volumn 138, Issue 3, 2010, Pages 1102-1111

  Karlsen, Tom H ^a   Franke, Andre ^b   Melum, Espen ^a   Kaser, Arthur ^c   Hov, Johannes Roksund ^a   Balschun, Tobias ^b   Lie, Benedicte A ^a   Bergquist, Annika ^d   Schramm, Christoph ^e   Weismüller, Tobias J ^f   Gotthardt, Daniel ^g   Rust, Christian ^h   Philipp, Eva E R ^b   Fritz, Teresa ^c   Henckaerts, Liesbet ⁱ   Weersma, Rinse K ^j   Stokkers, Pieter ^k   Ponsioen, Cyriel Y ^k   Wijmenga, Cisca ^j   Sterneck, Martina ^e   Nothnagel, Michael ^b   Hampe, Jochen ^b   Teufel, Andreas ^l   Runz, Heiko ^g   Rosenstiel, Philip ^b   Stiehl, Adolf ^g   Vermeire, Severine ⁱ   Beuers, Ulrich ^k   Manns, Michael P ^f   Schrumpf, Erik ^a   Boberg, Kirsten Muri ^a   Schreiber, Stefan ^b   more..

^a OSLO UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF KIEL   (Germany)

^c INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^d KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^e UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^f HANNOVER MEDICAL SCHOOL   (Germany)

^g UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^h UNIVERSITY OF MUNICH   (Germany)

ⁱ UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^j UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^k UNIVERSITY OF AMSTERDAM   (Netherlands)

^l JOHANNES GUTENBERG UNIVERSITY   (Germany)

more..

Author keywords

G Protein Coupled Bile Acid Receptor 1; Glypican 6; Inflammation; Macrophage Stimulating 1 (Hepatocyte Growth Factor Like)

Indexed keywords

G PROTEIN COUPLED BILE ACID RECEPTOR 1; G PROTEIN COUPLED RECEPTOR; GLYPICAN; GLYPICAN 6; HLA B ANTIGEN; MACROPHAGE ACTIVATING FACTOR; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; CHROMOSOME 13Q; CHROMOSOME 6P; CONTROLLED STUDY; FEMALE; GENE LOCUS; GENETIC SUSCEPTIBILITY; GENOME ANALYSIS; GENOTYPE; HLA SYSTEM; HUMAN; MAJOR CLINICAL STUDY; MALE; PHENOTYPE; PRIMARY SCLEROSING CHOLANGITIS; PRIORITY JOURNAL; SCHOOL CHILD; SINGLE NUCLEOTIDE POLYMORPHISM; ULCERATIVE COLITIS; UPREGULATION;

EID: 77249164222     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.gastro.2009.11.046     Document Type: Article

References (35)

1. Chapman R.W., Arborgh B.A., Rhodes J.M., et al. Primary sclerosing cholangitis: a review of its clinical features, cholangiography, and hepatic histology. Gut 21 (1980) 870-877
2. Boberg K.M., Aadland E., Jahnsen J., et al. Incidence and prevalence of primary biliary cirrhosis, primary sclerosing cholangitis, and autoimmune hepatitis in a Norwegian population. Scand J Gastroenterol 33 (1998) 99-103
3. Bambha K., Kim W.R., Talwalkar J., et al. Incidence, clinical spectrum, and outcomes of primary sclerosing cholangitis in a United States community. Gastroenterology 125 (2003) 1364-1369
4. Soetikno R.M., Lin O.S., Heidenreich P.A., et al. Increased risk of colorectal neoplasia in patients with primary sclerosing cholangitis and ulcerative colitis: a meta-analysis. Gastrointest Endosc 56 (2002) 48-54
5. Bergquist A., Montgomery S.M., Bahmanyar S., et al. Increased risk of primary sclerosing cholangitis and ulcerative colitis in first-degree relatives of patients with primary sclerosing cholangitis. Clin Gastroenterol Hepatol 6 (2008) 939-943
6. Schrumpf E., Fausa O., Forre O., et al. HLA antigens and immunoregulatory T cells in ulcerative colitis associated with hepatobiliary disease. Scand J Gastroenterol 17 (1982) 187-191
7. Karlsen T.H., Schrumpf E., and Boberg K.M. Genetic epidemiology of primary sclerosing cholangitis. World J Gastroenterol 13 (2007) 5421-5431
8. Horton R., Wilming L., Rand V., et al. Gene map of the extended human MHC. Nat Rev Genet 5 (2004) 889-899
9. Franke A., Balschun T., Karlsen T.H., et al. Replication of signals from recent studies of Crohn's disease identifies previously unknown disease loci for ulcerative colitis. Nat Genet 40 (2008) 713-715
10. Fisher S.A., Tremelling M., Anderson C.A., et al. Genetic determinants of ulcerative colitis include the ECM1 locus and five loci implicated in Crohn's disease. Nat Genet 40 (2008) 710-712
11. Silverberg M.S., Cho J.H., Rioux J.D., et al. Ulcerative colitis-risk loci on chromosomes 1p36 and 12q15 found by genome-wide association study. Nat Genet 41 (2009) 216-220
12. Franke A., Balschun T., Karlsen T.H., et al. Sequence variants in IL10, ARPC2 and multiple other loci contribute to ulcerative colitis susceptibility. Nat Genet 40 (2008) 1319-1323
13. Purcell S., Neale B., Todd-Brown K., et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 81 (2007) 559-575
14. WTCCC. Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 447 (2007) 661-678
15. Fukushima K., and Ueno Y. Bioinformatic approach for understanding the heterogeneity of cholangiocytes. World J Gastroenterol 12 (2006) 3481-3486
16. Wang X., and Seed B. A PCR primer bank for quantitative gene expression analysis. Nucleic Acids Res 31 (2003) e154
17. Baranzini S.E., Wang J., Gibson R.A., et al. Genome-wide association analysis of susceptibility and clinical phenotype in multiple sclerosis. Hum Mol Genet 18 (2009) 767-778
18. Comabella M., Craig D.W., Camina-Tato M., et al. Identification of a novel risk locus for multiple sclerosis at 13q31.3 by a pooled genome-wide scan of 500,000 single nucleotide polymorphisms. PLoS ONE 3 (2008) e3490
19. Weersma R.K., Stokkers P.C., Cleynen I., et al. Confirmation of multiple Crohn's disease susceptibility loci in a large Dutch-Belgian cohort. Am J Gastroenterol 104 (2009) 630-638
20. Filmus J., Capurro M., and Rast J. Glypicans. Genome Biol 9 (2008) 224
21. Capurro M., Wanless I.R., Sherman M., et al. Glypican-3: a novel serum and histochemical marker for hepatocellular carcinoma. Gastroenterology 125 (2003) 89-97
22. Goyette P., Lefebvre C., Ng A., et al. Gene-centric association mapping of chromosome 3p implicates MST1 in IBD pathogenesis. Mucosal Immunol 1 (2008) 131-138
23. Capurro M.I., Xiang Y.Y., Lobe C., et al. Glypican-3 promotes the growth of hepatocellular carcinoma by stimulating canonical Wnt signaling. Cancer Res 65 (2005) 6245-6254
24. Maruyama T., Miyamoto Y., Nakamura T., et al. Identification of membrane-type receptor for bile acids (M-BAR). Biochem Biophys Res Commun 298 (2002) 714-719
25. Keitel V., Donner M., Winandy S., et al. Expression and function of the bile acid receptor TGR5 in Kupffer cells. Biochem Biophys Res Commun 372 (2008) 78-84
26. Keitel V., Reinehr R., Gatsios P., et al. The G-protein coupled bile salt receptor TGR5 is expressed in liver sinusoidal endothelial cells. Hepatology 45 (2007) 695-704
27. Keitel V., Cupisti K., Ullmer C., et al. The membrane-bound bile acid receptor TGR5 is localized in the epithelium of human gallbladders. Hepatology 50 (2009) 861-870
28. Pall H., Zielenski J., Jonas M.M., et al. Primary sclerosing cholangitis in childhood is associated with abnormalities in cystic fibrosis-mediated chloride channel function. J Pediatr 151 (2007) 255-259
29. Zhou Y.Q., Chen Y.Q., Fisher J.H., et al. Activation of the RON receptor tyrosine kinase by macrophage-stimulating protein inhibits inducible cyclooxygenase-2 expression in murine macrophages. J Biol Chem 277 (2002) 38104-38110
30. Karlsen T.H., Boberg K.M., Olsson M., et al. Particular genetic variants of ligands for natural killer cell receptors may contribute to the HLA associated risk of primary sclerosing cholangitis. J Hepatol 46 (2007) 899-906
31. Vandiedonck C., Beaurain G., Giraud M., et al. Pleiotropic effects of the 8.1 HLA haplotype in patients with autoimmune myasthenia gravis and thymus hyperplasia. Proc Natl Acad Sci U S A 101 (2004) 15464-15469
32. Loftus Jr. E.V., Harewood G.C., Loftus C.G., et al. PSC-IBD: a unique form of inflammatory bowel disease associated with primary sclerosing cholangitis. Gut 54 (2005) 91-96
33. Karlsen T.H., Hampe J., Wiencke K., et al. Genetic polymorphisms associated with inflammatory bowel disease do not confer risk for primary sclerosing cholangitis. Am J Gastroenterol 102 (2007) 115-121
34. Bungay H.K., Buchel O.C., Cummings F., et al. Prevalence and determinants of primary sclerosing cholangitis in a cohort of patients with inflammatory bowel disease and normal liver function tests. Gut 57 (2008) A107
35. Duerr R.H., Taylor K.D., Brant S.R., et al. A genome-wide association study identifies IL23R as an inflammatory bowel disease gene. Science 314 (2006) 1461-1463